Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive COVID-19 treatment trial in the EU & UK
ISRCTN13035264Phase 3Completed
- Sponsor
- University of Minnesota
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Remdesivir with Placebo (2 arms). Primary endpoint: Time to recovery. Started Mar 2020; status: completed.
02
Drugs
remdesivir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN13035264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13035264.